510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

PTS Panels Chol+Glu Test Panel

K041750510(k) SpecialCleared Jul 23, 200424-day reviewClass II21 CFR 862.1345Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Polymer Technology Systems, Inc. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Jul 23, 2004 as substantially equivalent to K972669 (Polymer Technology Systems, Inc., 1998) and 2 other predicates after a 24-day review. Its family tree reaches back 3 generations to 1998. 1 later device descends from it. It has been recalled once.

Decided
Jul 23, 2004
Review
24 days
Class
Class II
Product code
NBW
Recalls
1
Predicates
3

Its longest line of descent runs back 3 generations to K980731 (1998). 5 ancestors in all, the oldest K972669 (1998). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1998: 2 other ancestors2016: 1 descendant cleared×2: 2 generations cleared close together, K980731 (1998), K982002 (1998) K013068 · Bioscanner 2000 · Polymer Technology Systems, Inc. · 2001 · recalled1995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors 1 generation forward: 1 descendant K013068 · Bioscanner 2000 · Polymer Technology Systems, Inc. · 2001 · recalledK982002 · Accu-Chek Comfort Curve Test Strip · Boehringer Mannheim Corp. · 1998 · recalledK980731 · Accu-Chek Comfort Curve Test Strips · Boehringer Mannheim Corp. · 19980
  1. Root · 3 generations backK980731 Accu-Chek Comfort Curve Test StripsBoehringer Mannheim Corp. · 1998
  2. 2 generations backK982002 Accu-Chek Comfort Curve Test StripBoehringer Mannheim Corp. · 1998 · Recalled
  3. 1 generation backK013068 Bioscanner 2000Polymer Technology Systems, Inc. · 2001 · Recalled
  4. This deviceK041750 PTS Panels Chol+Glu Test PanelPolymer Technology Systems, Inc. · 2004
  5. Descendant · cites it directly · 0 of its ownK162282 CardioChek Plus Test System, CardioChek Home Test SystemPolymer Technology Systems, Inc. D/B/A Pts Diagnostics · 2016 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K162282CardioChek Plus Test System, CardioChek Home Test SystemPolymer Technology Systems, Inc. D/B/A Pts Diagnostics · 2016 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K980731Accu-Chek Comfort Curve Test StripsBoehringer Mannheim Corp.1998—
−2K982002Accu-Chek Comfort Curve Test StripBoehringer Mannheim Corp.19981
−1K013068Bioscanner 2000Polymer Technology Systems, Inc.20011
0 (this device)K041750PTS Panels Chol+Glu Test PanelPolymer Technology Systems, Inc.2004—
+1K162282CardioChek Plus Test System, CardioChek Home Test SystemPolymer Technology Systems, Inc. D/B/A Pts Diagnostics20162

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199820

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
FIG. 1 — Lineage of K041750, 1998–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972669MTM Bioscanner 1000 Test System Consisting of MTM Bioscanner 1000 Meter, MTM Bioscanner…
Summary page 5
…Name: BioScanner (PTS PANELS) Cholesterol and Glucose Test Strips Device Company: Polymer Technology Systems, Inc. 510(k) Numbers: K972669, K981493, KO13068 Similarities and Differences between Chol+Gln Test Panel and the Predicate Devices:…
Polymer Technology Systems, Inc.1998—
*K981493MTM Bioscanner C Test Strips Model Number Bsa 200, Bsa 210, Bsa 220
Summary page 5
…Name: BioScanner (PTS PANELS) Cholesterol and Glucose Test Strips Device Company: Polymer Technology Systems, Inc. 510(k) Numbers: K972669, K981493, KO13068 Similarities and Differences between Chol+Gln Test Panel and the Predicate Devices:…
Polymer Technology Systems, Inc.19981
*K013068Bioscanner 2000Polymer Technology Systems, Inc.20011

Also cleared against K972669: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K162282CardioChek Plus Test System, CardioChek Home Test SystemPolymer Technology Systems, Inc. D/B/A Pts Diagnostics20160

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 14, 2018Class IIZ-1543-2018Under Investigation by firmPotential for loss of activity of the glucose analyte (under-recovery) prior to the full stated shelf life (August 2018)

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 2 companies; a new generation was cleared every 2.7 years on median.
  • 3 of the 5 ancestors have a recall of any class.
  • Of its descendants, K162282 (Polymer Technology Systems, Inc. D/B/A Pts Diagnostics, 2016) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K972669.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The Chol+Glu Test Panel is intended to measure cholesterol and glucose in whole blood on a BioScanner Plus (Cardidhek brand) analyzer. The test strips are intended to be used by healthcare professionals and individuals at home to measure blood cholesterol and glucose. Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders. Glucose measurements are used in the management of carbohydrate metabolism disorders.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K041750: PTS Panels Chol+Glu Test Panel.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K041750

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026